Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by biorunon May 03, 2021 1:50pm
209 Views
Post# 33115202

RE:RE:RE:Here goes Howard.....Back peddle Back peddle

RE:RE:RE:Here goes Howard.....Back peddle Back peddle

The core ones, that have significant materiality tied to them, are pushed out by 8 weeks to achieve all. It does not mean that any time in next four weeks we won't hit big time with at least one of these. But only time will tell. 

There is also a potential agreement with the Top 10, which is not on that list, so that could surprise us as well. Lets see.

The others are anti-aging and anti-viral, those have always been longer term initiatives, so I am not fussed here.

Overall the agenda is ambitious. The Wanbang proceeding to phase 2 could also come any day. It is listed on the public Fosun annual report as one of their listed clinical trials for small molecules. The list is not long, and shows that continued corporate commitment.

 

<< Previous
Bullboard Posts
Next >>